Jeffrey M. Leiden Sells 879 Shares of Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) Chairman Jeffrey M. Leiden sold 879 shares of the business’s stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $349.56, for a total transaction of $307,263.24. Following the completion of the sale, the chairman now owns 36,512 shares in the […]

Related Keywords

Canada , New Hampshire , United States , Sanfordc Bernstein , Piper Sandler , Sandy Spring Bank , Old North State Trust , News Ratings For Vertex Pharmaceuticals Daily , Quarter For Vertex Pharmaceuticals , Vertex Pharmaceuticals Trading , D More Investments Ltd , Steward Financial Group , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals Inc , Institutional Trading Of Vertex Pharmaceuticals , Vertex Pharmaceuticals , Royal Bank , Get Rating , Chairman Jeffrey , Pharmaceuticals Incorporated , Spring Bank , Investments Ltd , Financial Group , North State Trust , New Hampshire Trust , Vertex Pharmaceuticals Daily , Nasdaq Vrtx , Vrtx , Medical , 92532f10 , Insider Trading , Nsider Trades , Tocks ,